PRIMARY HYPOTHYROIDISM AND I-131 METAIODOBENZYLGUANIDINE THERAPY IN NEUROBLASTOMA

被引：7

作者：

PICCO, P

GARAVENTA, A

CLAUDIANI, F

GARIBALDI, L

BORRONE, C

机构：

[1] CARDINAL GLENNON CHILDRENS HOSP,ST LOUIS,MO

[2] OSPED GALLIERA,GERONA,ITALY

来源：

LANCET | 1993年 / 342卷 / 8862期

关键词：

D O I：

10.1016/0140-6736(93)91925-C

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：57 / 57

页数：1

共 4 条

[1]

GARAVENTA A, 1991, CANCER, V67, P922, DOI 10.1002/1097-0142(19910215)67:4<922::AID-CNCR2820670411>3.0.CO

[2]

2-D

[3] 131-I-METAIODOBENZYLGUANIDINE TREATMENT IN PATIENTS WITH REFRACTORY ADVANCED NEUROBLASTOMA [J].

HUTCHINSON, RJ ;

SISSON, JC ;

SHAPIRO, B ;

MISER, JS ;

NORMOLE, D ;

SHULKIN, BL ;

FRANCIS, IR ;

ZASADNY, K ;

CAREY, JE ;

JOHNSON, JW ;

MALLETTE, SA ;

MUDGETTE, B .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03) :226-232

[4] METAIODOBENZYLGUANIDINE (MLBG) IN TREATMENT OF 47 PATIENTS WITH NEUROBLASTOMA - RESULTS OF THE GERMAN NEUROBLASTOMA TRIAL [J].

KLINGEBIEL, T ;

BERTHOLD, F ;

TREUNER, J ;

SCHWABE, D ;

FISCHER, M ;

FEINE, U ;

MAUL, FD ;

WATERS, W ;

WEHINGER, H ;

NIETHAMMER, D .

MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (02) :84-88

← 1 →